Press Release Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 55 minutes ago
Press Release Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer Jul 28